EGYHF 2022 - Session 1 Difficult to treat heart failure patients
EGYHF 2022 - ACTO Symposium
EGYHF 2022 - Session 2 Prevention of sudden death in heart failure
EGYHF 2022 - Session 3 Acute Heart Failure
EGYHF 2022 - Servier Symposium
EGYHF 2022 - Novartis Symposium
EGYHF 2022 - Opening Ceremony
EGYHF 2022 - Session 4 Device therapy in HFrEF
EGYHF 2022 - Session 5 Prevention of Heart Failure
EGYHF 2022 - Boehringer Ingelheim Symposium
EGYHF 2022 - Session 6 Optimizing medical care for patients with HFrEF
EGYHF 2022 - AstraZeneca Symposium
EGYHF 2022 - Session 7 Heart Failure with preserved Ejection Fraction
EGYHF 2022 - Biofactor Macyrl Symposium
EGYHF 2022 - Bayer Symposium
EGYHF 2022 - Session 8 The challenges in HF
EGYHF 2022 - Session 9 Specific Challenges in Heart Failure
EGYHF 2022 - Session 1 Difficult to treat heart failure patients
EGYHF 2022 - ACTO Symposium
EGYHF 2022 - Session 2 Prevention of sudden death in heart failure
EGYHF 2022 - Session 3 Acute Heart Failure
EGYHF 2022 - Servier Symposium
EGYHF 2022 - Novartis Symposium
EGYHF 2022 - Opening Ceremony
EGYHF 2022 - Session 4 Device therapy in HFrEF
EGYHF 2022 - Session 5 Prevention of Heart Failure
EGYHF 2022 - Boehringer Ingelheim Symposium
EGYHF 2022 - Session 6 Optimizing medical care for patients with HFrEF
EGYHF 2022 - AstraZeneca Symposium
EGYHF 2022 - Session 7 Heart Failure with preserved Ejection Fraction
EGYHF 2022 - Biofactor Macyrl Symposium
EGYHF 2022 - Bayer Symposium
EGYHF 2022 - Session 8 The challenges in HF
EGYHF 2022 - Session 9 Specific Challenges in Heart Failure
